Drug Database
Back to search

Belgium· BE-AMP-SAM058396-00

Daraprim 25 mg

A pyrimethamine product containing pyrimethamine, registered in Belgium by GlaxoSmithKline Pharmaceuticals. The same ATC class is registered in 9 of our 19 countries.

ATC P01BD01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDaraprim 25 mgATCP01BD01REGISTER NO.BE-AMP-SAM058396-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pyrimethamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pyrimethamine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BD01 (pyrimethamine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search pyrimethamine products by name

Pyrimethamine · ATC P01BD01

9 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyrimethamine costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.97 in France to $3.75 in Switzerland — a ×3.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pyrimethamine · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.75
  • FR France$0.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pyrimethamine
Manufacturer
GlaxoSmithKline Pharmaceuticals
Country
Belgium (BE)
ATC code
P01BD01
ATC class
Pyrimethamine
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0033571

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for pyrimethamine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pyrimethamine against other medicinesHow interaction checks work

Pyrimethamine · interactions on record

48 records

  • 4 severe
  • 28 moderate
  • 2 minor
  • 14 info

Most severe, free to view

  • Sodium aurothiomalateM01CB01severe
  • AuranofinM01CB03severe
  • AurothioglucoseM01CB04severe
  • DeferiproneV03AC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyrimethamine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyrimethamine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Daraprim
  • Spain · Daraprim
  • United Kingdom (Northern Ireland) · Daraprim
  • Luxembourg · Daraprim
  • Netherlands · Daraprim
  • Portugal · Pirimetamina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca0257c8-6f00-4241-908c-1f3e2efd918b
GET /v1/drugs/ca0257c8-6f00-4241-908c-1f3e2efd918b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Daraprim 25 mg",
  "name_fr": "Daraprim 25 mg",
  "name_nl": "Daraprim 25 mg",
  "amp_code": "SAM058396-00",
  "strengths": [
    "25.0000",
    "25.0000",
    "0.1250",
    "90.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Pyrimethamine",
    "Docusate Sodium",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pyrimethamine",
  "authorisation_numbers": [
    "BE058396"
  ]
}
API referenceMCP serverPlans

See everything about pyrimethamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console